Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127133711 | 12713371 | 1 | I | 20160823 | 20160903 | 20160903 | EXP | JP-ASTRAZENECA-2016SE93798 | ASTRAZENECA | 67.00 | YR | M | Y | 0.00000 | 20160903 | PH | JP | JP |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
127133711 | 12713371 | 1 | PS | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | 50706 | 1.5 | G | SOLUTION FOR INJECTION | QD | |||||||
127133711 | 12713371 | 2 | SS | ACETAMINOPHEN. | ACETAMINOPHEN | 1 | Unknown | U | 0 | ||||||||||
127133711 | 12713371 | 3 | C | DALACIN | CLINDAMYCINCLINDAMYCIN PHOSPHATE | 1 | 0 |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
127133711 | 12713371 | 1 | Infection |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
127133711 | 12713371 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
127133711 | 12713371 | Alanine aminotransferase increased | |
127133711 | 12713371 | Aspartate aminotransferase increased | |
127133711 | 12713371 | Hepatic function abnormal |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |